Year archive

NYRADA INC. — 2026 filings

All 39 regulatory filings released by NYRADA INC. (NYR) in 2026, sourced directly from the official regulator.

39 Filings

2026 Period

2026 filings (39)

Filing	Released	Lang
Nyrada Receives Notice of Allowance for Xolatryp US Patent 3 pages 350.9KB Regulatory Filings	2026-05-18	English
Pause in Trading 1 Regulatory Filings	2026-05-18	English
Trading Halt 3 pages 522.2KB Regulatory Filings	2026-05-18	English
First Site Activated in Nyradas PROTECT-MI Phase IIa Trial 6 pages 383.6KB Regulatory Filings	2026-04-21	English
Quarterly Activities Report and Appendix 4C 9 pages 643.1KB Interim / Quarterly Report Q3 2026	2026-04-14	English
Presentation - ASX SMIDCaps Conference 12 pages 1.3MB Regulatory Filings	2026-03-19	English
Nyrada PROTECT-MI Phase IIa Trial To Commence 6 pages 386.1KB Regulatory Filings	2026-03-18	English
Change of Director's Interest Notice - JM 3 pages 7.0KB Regulatory Filings	2026-03-08	English
Notification regarding unquoted securities - NYR 12 pages 41.7KB Regulatory Filings	2026-02-19	English
Change of Director's Interest Notice - CC 3 pages 7.3KB Regulatory Filings	2026-02-19	English
Change of Director's Interest Notice - ID 3 pages 7.4KB Regulatory Filings	2026-02-19	English
Change of Director's Interest Notice - JM 3 pages 7.1KB Regulatory Filings	2026-02-19	English
Change of Director's Interest Notice - MF 3 pages 7.1KB Regulatory Filings	2026-02-19	English
Change of Director's Interest Notice - RW 3 pages 7.1KB Regulatory Filings	2026-02-19	English
Director Options Issue 2 pages 280.9KB Regulatory Filings	2026-02-19	English
Appendix 4D and Half Year Report to 31 December 2025 20 pages 595.8KB Regulatory Filings	2026-02-17	English
Nyrada Half Year FY2026 Results 5 pages 391.0KB Regulatory Filings	2026-02-17	English
Top 20 CDI Holder List 4 pages 347.3KB Regulatory Filings	2026-02-17	English
Capital Structure Update 3 pages 326.3KB Regulatory Filings	2026-02-17	English
Nyrada Phase IIa Clinical Trial Factsheet 6 pages 289.5KB Regulatory Filings	2026-02-04	English
Investor Update Webinar 18 pages 4.1MB Regulatory Filings	2026-02-04	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2026-02-04	English
Cleansing Statement 2 pages 232.4KB Regulatory Filings	2026-02-04	English
Update to Nyrada Substantial Holders 2 pages 232.0KB Regulatory Filings	2026-01-28	English
Change in substantial holding - M Azzi 2 pages 230.4KB Regulatory Filings	2026-01-28	English
Change in substantial holding - Matt Corp WA PL 2 pages 261.0KB Regulatory Filings	2026-01-28	English
Nyrada Investor Webinar 2 pages 254.0KB Regulatory Filings	2026-01-27	English
Quarterly Activities Report and Appendix 4C 9 pages 542.5KB Regulatory Filings	2026-01-22	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2026-01-22	English
Cleansing Statement 2 pages 232.6KB Regulatory Filings	2026-01-22	English
Notification of cessation of securities - NYR 4 pages 14.8KB Regulatory Filings	2026-01-18	English
Change of Director's Interest Notice - ID 2 pages 5.8KB Regulatory Filings	2026-01-18	English
Application for quotation of securities - NYR 7 pages 21.4KB Regulatory Filings	2026-01-12	English
Cleansing Statement 2 pages 232.6KB Regulatory Filings	2026-01-12	English
Application for quotation of securities - NYR 8 pages 24.0KB Regulatory Filings	2026-01-11	English
Cleansing Statement 2 pages 232.6KB Regulatory Filings	2026-01-11	English
Nyrada Phase IIa Clinical Trial Approved to Commence 5 pages 276.3KB Regulatory Filings	2026-01-07	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2026-01-05	English
Cleansing Statement 2 pages 232.6KB Regulatory Filings	2026-01-05	English